Skip to main content
. Author manuscript; available in PMC: 2022 Sep 15.
Published in final edited form as: Vaccine. 2021 Aug 13;39(39):5650–5657. doi: 10.1016/j.vaccine.2021.08.003

Figure 6.

Figure 6.

NHP immunogenicity from Study C with IgG responses against (a) EBOV-GP, (b) SUDV-GP, and (c) MARV-GP. Data are shown as GMTs from n = 3 animals per group, except for the CoV10 group with n = 1. The dotted line represents the limit of quantification (LOQ). If any primate in a group had a response less than the LOQ, the GMT is shown as half the LOQ. The numbers in the group labels are defined in Table 1 and refer to the dose of antigen (in μg) and adjuvant (in mg).